Literature DB >> 11337137

A guinea pig model of low-dose Mycobacterium bovis aerogenic infection.

M A Chambers1, A Williams, D Gavier-Widén, A Whelan, C Hughes, G Hall, M S Lever, P D Marsh, R G Hewinson.   

Abstract

In order to develop a model of Mycobacterium bovis infection with pathogenetical relevance, a modified version of the Henderson apparatus was used to deliver infectious aerosols directly to the snouts of guinea pigs. Aerosols generated from 10(6), 10(7), 10(8)CFU/ml M. bovis suspensions established disease in every animal, with estimated retained doses of 10, 100, 1000 CFU, respectively. For comparison, other guinea pigs were inoculated with 100 CFU M. bovis intramuscularly (i.m.). Pathology and bacterial colonisation of lungs and spleen varied according to the dose and route of inoculation. Animals inoculated i.m. gave a significant cutaneous tuberculin hypersensitivity reaction earlier after testing than those infected aerogenically. A serological response to M. bovis antigens was detected in all infected animals. Intensity of antigen recognition was dose-dependent and although the range of antigens recognised varied between animals, a 25 kDa antigen present in the cell fraction was serodominant. Thus, a reproducible guinea pig model has been defined that may be suitable for virulence, vaccination, and immunological studies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11337137     DOI: 10.1016/s0378-1135(00)00378-3

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  6 in total

1.  Responses to tuberculin among Zebu cattle in the transhumance regions of Karamoja and Nakasongola district of Uganda.

Authors:  J Oloya; J Opuda-Asibo; B Djønne; J B Muma; G Matope; R Kazwala; E Skjerve
Journal:  Trop Anim Health Prod       Date:  2006-05       Impact factor: 1.559

2.  Vaccination of guinea pigs with DNA encoding the mycobacterial antigen MPB83 influences pulmonary pathology but not hematogenous spread following aerogenic infection with Mycobacterium bovis.

Authors:  Mark A Chambers; Ann Williams; Graham Hatch; Dolores Gavier-Widén; Graham Hall; Kris Huygen; Douglas Lowrie; Philip D Marsh; R Glyn Hewinson
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

3.  Oral vaccination of guinea pigs with a Mycobacterium bovis bacillus Calmette-Guerin vaccine in a lipid matrix protects against aerosol infection with virulent M. bovis.

Authors:  Simon Clark; Martin L Cross; Allan Nadian; Julia Vipond; Pinar Court; Ann Williams; R Glyn Hewinson; Frank E Aldwell; Mark A Chambers
Journal:  Infect Immun       Date:  2008-06-02       Impact factor: 3.441

4.  Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases.

Authors:  Naomi F Walker; Simon O Clark; Tolu Oni; Nuria Andreu; Liku Tezera; Shivani Singh; Luísa Saraiva; Bernadette Pedersen; Dominic L Kelly; Julia A Tree; Jeanine M D'Armiento; Graeme Meintjes; Francesco A Mauri; Ann Williams; Robert J Wilkinson; Jon S Friedland; Paul T Elkington
Journal:  Am J Respir Crit Care Med       Date:  2012-02-16       Impact factor: 21.405

Review 5.  The role of badgers in the epidemiology of Mycobacterium bovis infection (tuberculosis) in cattle in the United Kingdom and the Republic of Ireland: current perspectives on control strategies.

Authors:  Deirdre Ní Bhuachalla; Leigh Al Corner; Simon J More; Eamonn Gormley
Journal:  Vet Med (Auckl)       Date:  2014-12-19

6.  Surveillance of coyotes to detect bovine tuberculosis, Michigan.

Authors:  Kurt C VerCauteren; Todd C Atwood; Thomas J DeLiberto; Holly J Smith; Justin S Stevenson; Bruce V Thomsen; Thomas Gidlewski; Janet Payeur
Journal:  Emerg Infect Dis       Date:  2008-12       Impact factor: 6.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.